1-11 of 11
Andrew J. Menssen
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Fusion-harboring mast cells can explain molecular positivity in flow cytometric MRD-negative core-binding factor AML

Jacqueline A. Cook, Loren Lott, Jenna Perry, Ashley M. Eckel, Dongbin Xu, Chad A. Hudson, Denise A. Wells, Michael R. Loken, Andrew J. Menssen
Journal: Blood
Blood (2024) 144 (5): 581–585.
https://doi.org/10.1182/blood.2024024264
Published: 2024
Includes: Supplemental data
Journal Articles

Reduced Subclone Diversity in Clonal Cytopenia of Undetermined Significance Compared to Myelodysplastic Syndrome

Monique Chavez, Sridhar N Srivatsan, Christopher A Miller, Andrew J. Menssen, Ajay Khanna, Jin Shao, Catrina Fronick, Robert Fulton, Sharon E Heath, Constantine Logothetis, Tasha Burton, Victoria Donaldson, Claudia Cabrera, Raya Saba, Kiran R. Vij, Eric J. Duncavage, Meagan Jacoby, Matthew J. Walter
Journal: Blood
Blood (2023) 142 (Supplement 1): 2696.
https://doi.org/10.1182/blood-2023-189591
Published: 2023
Journal Articles

Residual Mast Cells Can Explain Persistent Molecular Positivity in Difference from Normal Flow Cytometric-Defined MRD Negative Core Binding Factor AML

Jacqueline A. Cook, Loren Lott, Jenna Perry, Arun Nalla, Dongbin Xu, Chad A. Hudson, Denise A. Wells, Michael R. Loken, Andrew J. Menssen
Journal: Blood
Blood (2023) 142 (Supplement 1): 426.
https://doi.org/10.1182/blood-2023-180275
Published: 2023
Journal Articles

CD276 (B7-H3) Is an Immunotherapeutic Target in Acute Myeloid Leukemia with Preclinical Efficacy of Vobramitamab Duocarmazine, an Investigational CD276 Antibody-Drug Conjugate

Danielle C Kirkey, Melia Blankenfeld, Tiffany Hylkema, Deryk Loo, Ashley Ward, Leila Robinson, Jack H Peplinski, Logan K Wallace, Laura Pardo, Andrew J. Menssen, Rhonda E Ries, Soheil Meshinchi
Journal: Blood
Blood (2023) 142 (Supplement 1): 5958.
https://doi.org/10.1182/blood-2023-187450
Published: 2023
Journal Articles

CXCR4 (CD184) Expression in Pediatric AML Is Associated with Bone Marrow Retention, Specific Disease Characteristics, and Worse Outcomes: A Report of 1004 Patients from the Children's Oncology Group AAML1031 Protocol

Andrew J. Menssen, Chad A. Hudson, Todd A. Alonzo, Robert B. Gerbing, Laura Pardo, Fan-Chi Hsu, Loren L. Lott, Fangyan Dai, Keely Ghiradelli, Yi-Cheng Wang, E. Anders Kolb, Todd M. Cooper, Jessica A. Pollard, Michael R. Loken, Richard Aplenc, Lisa Eidenschink Brodersen, Soheil Meshinchi
Journal: Blood
Blood (2022) 140 (Supplement 1): 3452–3453.
https://doi.org/10.1182/blood-2022-163682
Published: 2022
Journal Articles

Signaling Gene Mutations Are Characterized By Diverse Patterns of Expansion and Contraction during Progression from MDS to Secondary AML

Andrew J Menssen, BA, Ajay Khanna, Christopher A Miller, PhD, Gue Su Chang, PhD, Jin J Shao, Sridhar Nonavinkere Srivatsan, MS, Joshua Robinson, Michelle O'Laughlin, Catrina Fronick, BS, Robert Fulton, MS, Kimberly J Brendel, Sharon E Heath, Peter Westervelt, MDPhD, John F. DiPersio, MD PhD, Daniel C. Link, MD, Meagan A. Jacoby, Eric Duncavage, MD, Timothy J Ley, MD, Matthew J. Walter, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 2–3.
https://doi.org/10.1182/blood-2020-140394
Published: 2020
Journal Articles

Genetics of progression from MDS to secondary leukemia

Andrew J. Menssen, Matthew J. Walter
Journal: Blood
Blood (2020) 136 (1): 50–60.
https://doi.org/10.1182/blood.2019000942
Published: 2020
Journal Articles

Down Syndrome AML Is Unique in Phenotype Both at Diagnosis and in Post Chemotherapy Regeneration

Elisabeth R Wilson, Lisa Eidenschink Brodersen, PhD, Barbara Katharina Zehentner, PhD, Andrew J. Menssen, Andrew P. Voigt, Laura Pardo, Denise A. Wells, MD, Johann Hitzler, MD FRCP (C), FAAP, Jason N. Berman, MD, Todd A. Alonzo, PhD, Samir B. Kahwash, Soheil Meshinchi, MD PhD, Michael R. Loken, PhD
Journal: Blood
Blood (2016) 128 (22): 1687.
https://doi.org/10.1182/blood.V128.22.1687.1687
Published: 2016
Journal Articles

A Recurrent Immunophenotype at Diagnosis Independently Identifies High Risk Pediatric AML: A Report from the Children's Oncology Group Trial AAML0531

Lisa Eidenschink Brodersen, PhD, Todd A. Alonzo, PhD, Andrew J. Menssen, Robert B. Gerbing, MA, Laura Pardo, Andrew P. Voigt, Samir B. Kahwash, Betsy A. Hirsch, PhD, Susana C. Raimondi, PhD, Alan S. Gamis, MD MPH, Soheil Meshinchi, MD PhD, Michael R. Loken, PhD
Journal: Blood
Blood (2015) 126 (23): 560.
https://doi.org/10.1182/blood.V126.23.560.560
Published: 2015
Journal Articles

Heirarchical Clustering of Immunophenotypic Cell Surface Antigen Expression Identifies Clinically Meaningful Cohorts in Childhood AML: A Report from the Children's Oncology Group Protocol AAML0531

Michael R. Loken, PhD, Andrew P. Voigt, Robert B. Gerbing, MA, Lisa Eidenschink Brodersen, PhD, Andrew J. Menssen, Laura Pardo, Alan S. Gamis, MD MPH, Todd A. Alonzo, PhD, Soheil Meshinchi, MD PhD
Journal: Blood
Blood (2015) 126 (23): 561.
https://doi.org/10.1182/blood.V126.23.561.561
Published: 2015
Journal Articles

Recurrent Genetic Abnormalities Are Reflected in Phenotype at Diagnosis in Pediatric Acute Myeloid Leukemia: A Report from the Children's Oncology Group Protocol AAML0531

Andrew P. Voigt, Lisa Eidenschink Brodersen, PhD, Robert B. Gerbing, MA, Andrew J. Menssen, Betsy A. Hirsch, PhD, Susana C. Raimondi, PhD, Alan S. Gamis, MD MPH, Todd A. Alonzo, PhD, Soheil Meshinchi, MD PhD, Michael R. Loken, PhD
Journal: Blood
Blood (2015) 126 (23): 1377.
https://doi.org/10.1182/blood.V126.23.1377.1377
Published: 2015